| __timestamp | Incyte Corporation | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 508491000 | 2614539000 |
| Thursday, January 1, 2015 | 726779000 | 3711019000 |
| Friday, January 1, 2016 | 1047532000 | 4560733000 |
| Sunday, January 1, 2017 | 1456737000 | 5475166000 |
| Monday, January 1, 2018 | 1787760000 | 6276700000 |
| Tuesday, January 1, 2019 | 2044510000 | 7081200000 |
| Wednesday, January 1, 2020 | 2535374000 | 7377200000 |
| Friday, January 1, 2021 | 2835276000 | 13634200000 |
| Saturday, January 1, 2022 | 3187638000 | 10612500000 |
| Sunday, January 1, 2023 | 3440649000 | 11301400000 |
| Monday, January 1, 2024 | 3929149000 | 12231500000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biotechnology, Regeneron Pharmaceuticals, Inc. and Incyte Corporation have showcased remarkable growth in gross profit over the past decade. From 2014 to 2023, Regeneron has consistently outperformed Incyte, with its gross profit peaking at approximately $11.3 billion in 2023, a staggering 330% increase from 2014. Incyte, while trailing, has demonstrated impressive growth, with a 577% increase, reaching around $3.4 billion in the same period.
This data highlights the dynamic nature of the biotech industry, where innovation and strategic investments drive financial success.
Key Insights on Gross Profit: Novartis AG vs Incyte Corporation
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Regeneron Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Regeneron Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc: A Detailed Gross Profit Analysis
Regeneron Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Regeneron Pharmaceuticals, Inc. and MorphoSys AG
Who Generates Higher Gross Profit? Regeneron Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Genmab A/S and Incyte Corporation: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Incyte Corporation or Jazz Pharmaceuticals plc
Gross Profit Comparison: Incyte Corporation and BioMarin Pharmaceutical Inc. Trends
Gross Profit Analysis: Comparing Incyte Corporation and Vericel Corporation